States Move to Ban “Gas Station Heroin” as Tianeptine Abuse Sparks Health Alarms
Tianeptine, nicknamed “gas station heroin,” is an unapproved antidepressant sold as a supplement in the U.S., producing opioid-like euphoria and life-threatening respiratory depression; rising misuse has prompted multiple states to move to ban or schedule it.
Key takeaways
- Unapproved and misbranded: Tianeptine is not approved in the U.S. but is sold as a dietary supplement with misleading health claims.
- Opioid-like danger: At high doses it stimulates mu-opioid receptors, producing euphoria, addiction and risk of fatal respiratory depression.
- State responses: At least 14 states have moved to schedule or ban tianeptine; Connecticut most recently prohibited sale and use.
- Hard to detect: It may not appear on routine drug screens, complicating diagnosis and treatment of severe poisonings.
Main story
What tianeptine is and how it is sold
Tianeptine is a tricyclic antidepressant used at controlled medical doses in parts of Europe, Asia and South America, but it is not approved in the United States. Instead, sellers market it here as a dietary supplement, a nootropic, or a pain and anxiety aid, often with packaging and labels that make unverified claims. The Mayo Clinic and other health authorities note these misrepresentations.
Products come in pills, powders, salts and liquids, often flavored and packaged to appeal to young people. Common brand names include Zaza, Neptune’s Fix, Pegasus, Tianaa and TD Red. Availability in convenience stores, gas stations, vape shops and online is central to public health concerns; the U.S. Food and Drug Administration has documented these marketing channels and risks.
How it works and why it can be deadly
Tianeptine has complex pharmacology: at low doses it affects serotonin reuptake, but at high doses—far above therapeutic doses used abroad—it activates mu-opioid receptors, the same receptor system targeted by heroin and morphine. That opioid activity explains reports of intense euphoria, rapid dependence and severe overdose risk. The National Center for Biotechnology Information and clinical reports note potency that can exceed morphine at certain exposures.
Medical risks: Increasing doses raise the likelihood of life-threatening respiratory depression, profound sedation and cardiac arrest. The FDA has reported severe adverse events and deaths linked to exposure.
Health risks and reported cases
Reported adverse events include slowed breathing, severe sedation, coma, seizures, arrhythmias, high blood pressure, nausea and death. Because tianeptine may not show up on routine drug screens, clinicians can face difficulty diagnosing and treating critically ill patients. The New Jersey Department of Health issued an alert after a 2024 cluster tied to a product called “Neptune’s Fix” that contained both tianeptine and synthetic cannabinoids; that outbreak produced deaths, seizures and serious cardiac events.
Withdrawal and addiction
Users can develop dependence and severe withdrawal syndromes similar to opioid withdrawal. Abrupt cessation can trigger intense cravings, sweating, muscle aches, chills, tremors, anxiety and deep depression. Some individuals report daily doses in the thousands of milligrams—far beyond therapeutic levels used elsewhere—greatly increasing risk.
State action: tianeptine state restrictions and bans
States have moved quickly: at least 14 have designated tianeptine as a Schedule I controlled substance or enacted other restrictions. Connecticut recently banned sale and use and added other substances to its schedule, citing candy-like flavors and misleading marketing that target young people and those with substance-use disorders. VCU Health reports that Virginia and North Carolina have also taken action, and other states are reviewing measures.
Federal and public health response
The FDA warns consumers that tianeptine is not an approved dietary supplement and highlights a rise in poison center calls since 2016, including severe cases requiring intensive care. FDA leadership described the trend as a
“dangerous and growing health trend.”
Clinicians and poison centers are urged to consider tianeptine when patients present with unexplained opioid-like or neurologic symptoms.
Marketing, distribution and consumer risks
Despite warnings, online sellers and some retailers continue to market tianeptine with misleading claims about treating depression, pain or improving alertness. Candy-like flavors and packaging raise the risk that minors will try these products. Unregulated sales across gas stations, convenience stores and online marketplaces complicate enforcement and public messaging; see reporting from the Mayo Clinic and VCU Health.
Voices from the field
Emergency physicians treating overdoses urge stronger action: at high doses tianeptine behaves like an opioid and can cause rapid respiratory failure. Clinicians have publicly called for national regulation, arguing the drug has no place on store shelves.
Implications for the United States of America
- Public safety and law enforcement: State bans and Schedule I listings reflect a law-and-order strategy to curb illicit distribution and will require coordination among police, health agencies and retailers.
- Health system impact: Hospitals and poison centers may see continued strain; clinicians must expand testing and suspicion because tianeptine can evade routine drug screens.
- Protecting families and youth: Candy-like flavors and gas-station placement risk exposing teens; public education campaigns are needed to alert parents and schools.
- Policy and regulation: Patchwork state actions highlight gaps in federal regulation; policymakers may face pressure to consider nationwide controls to close loopholes.
- Treatment and recovery: Communities should prepare for increased demand for treatment, withdrawal support and harm-reduction services; the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline offers 24/7 confidential referrals.
Help and resources
If you or someone you know is struggling with substance misuse, the SAMHSA National Helpline can provide free, confidential referrals and support 24/7 in English and Spanish. Seek immediate emergency care for signs of severe respiratory depression, coma, seizures or other life-threatening symptoms.
